Ineffectiveness of Intermittent Hemodialysis in a Critically Ill COVID-19 Patient: A Case of Persistent Heparin-Induced Hyperkalemia.
Journal
Case reports in nephrology
ISSN: 2090-6641
Titre abrégé: Case Rep Nephrol
Pays: United States
ID NLM: 101598418
Informations de publication
Date de publication:
2022
2022
Historique:
received:
13
08
2021
revised:
20
11
2021
accepted:
19
01
2022
entrez:
14
3
2022
pubmed:
15
3
2022
medline:
15
3
2022
Statut:
epublish
Résumé
Heparin is widely used in the intensive care unit despite the risk of bleeding it can cause. Although it is rarely reported, hyperkalemia is one of the side effects associated with heparin therapy (unfractionated or fractionated heparin). It would be secondary to hypoaldosteronism by blocking the biosynthesis of aldosterone in the adrenal gland and often appears in context of prolonged heparin therapy or inappropriate renin production in elderly, diabetic, and kidney insufficiency patients. We report a case of persistent hyperkalemia in a diabetic COVID-19 patient treated with curative heparin in the context of severe COVID-19.
Identifiants
pubmed: 35284145
doi: 10.1155/2022/8613656
pmc: PMC8916869
doi:
Types de publication
Case Reports
Langues
eng
Pagination
8613656Informations de copyright
Copyright © 2022 Yannick M. Nlandu et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Circ Res. 2020 May 8;126(10):1456-1474
pubmed: 32264791
J Am Soc Nephrol. 2011 Nov;22(11):1981-9
pubmed: 21980112
Ann Intensive Care. 2019 Feb 28;9(1):32
pubmed: 30820692
Indian J Crit Care Med. 2013 Nov;17(6):388-91
pubmed: 24501495
J Pharmacol Pharmacother. 2011 Oct;2(4):266-9
pubmed: 22025855
Ann Intensive Care. 2020 Sep 16;10:124
pubmed: 32953201